Importance of receptor binding in the immunogenicity, adjuvanticity and therapeutic properties of cholera toxin and Escherichia coli heat-labile enterotoxin.
Nashar
T O
TO
Department of Pathology and Microbiology, University of Bristol, School of Medical Sciences, UK. t.o.nashar@bristol.ac.uk
Williams
N A
NA
Hirst
T R
TR
D000276:Adjuvants, Immunologic; D000818:Animals; D001327:Autoimmune Diseases / Q000517:prevention & control; D001427:Bacterial Toxins / Q000276:immunology* / Q000627:therapeutic use; D002772:Cholera Toxin / Q000276:immunology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004768:Enterotoxins / Q000276:immunology* / Q000627:therapeutic use; D029968:Escherichia coli Proteins; D006801:Humans; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D002772:Cholera Toxin; C027538:heat-labile enterotoxin, E coli